medigraphic.com
ISSN 2539-0859 (Electronic)
ISSN 0120-8411 (Print)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)

2020, Number 3

<< Back Next >>

Acta de Otorrinolaringología CCC 2020; 48 (3)

Characterization of the population that consults by epistaxis to the Otolaryngology Service of the Hospital Universitario Mayor Méderi (HUM)

Alfaro ALI, Hernández LML, Daza VJA

Language: Spanish
References: 18
Page: 232-238
PDF size: 262.37 Kb.


ABSTRACT

Background: epistaxis is one of the main reasons for emergency consultations in the Otolaryngology department. Most episodes originate in the anterior nasal septum and their management tends to be conservative. Aim: characterize the population that consults by epistaxis to the Otolaryngology department of the Hospital Universitario Mayor Méderi (HUM) between March 2017 and February 2018. Methods: observational, descriptive, cross-sectional study, with retrospective data collection of patients admitted to the emergency department of the HUM by epistaxis, registered in the database of the Otolaryngology Department. Demographic data, location of bleeding, treatment, comorbidities, drugs, and blood pressure were analyzed. Results: a total of 587 patients; 57 % women with an average of 66 years +/- 16.15 years. The most frequent comorbidity was arterial hypertension (60 %) and 26 % of the patients presented blood pressure levels ›140/90 mm Hg. In pharmacological history, 64.9 % belonged to the group of antihypertensives and 37.6 % to antiplatelet agents. The location of the bleeds was anterior (› Cottle area II). The main treatment was the anterior nasal gauze packing (36.4 %), followed by silver nitrate cauterization (36.1 %). Conclusions: in the HUM, patients who consult for epistaxis are middle-aged and elderly adults, with anterior localization of nasal bleeding, which only required medical management. Other studies are required to determine the most effective treatment modality according to the severity of epistaxis.


REFERENCES

  1. Bequignon E, Vérillaud B, Robard L, Michel J, PrulièreEscabasse V, Crampette L, et al. Guidelines of the FrenchSociety of Otorhinolaryngology (SFORL). First-line treatmentof epistaxis in adults. Eur Ann Otorhinolaryngol Head NeckDis. 2017;134(3):185-9. doi:10.1016/j.anorl.2016.09.008

  2. Al-bar MH. Epistaxis and catastrophic nasal bleeding. OperTech Otolaryngol - Head Neck Surg. 2014;25(2):194-200. doi:10.1016/j.otot.2014.02.010

  3. Davies K, Batra K, Mehanna R, Keogh I. Pediatric epistaxis:epidemiology, management & impact on quality of life. Int JPediatr Otorhinolaryngol. 2014;78(8):1294-97. doi:10.1016/j.ijporl.2014.05.013

  4. Kasperek ZA, Pollock GF. Epistaxis: an overview. EmergMed Clin North Am. 2013;31(2):443-454. doi:10.1016/j.emc.2013.01.008

  5. Kindler RM, Holzmann D, Landis BN, Ditzen B, Soyka MB.The high rate of long-term recurrences and sequelae afterepistaxis treatment. Auris Nasus Larynx. 2016;43(4):412-7.doi:10.1016/j.anl.2015.09.011

  6. Verillaud B, Robard L, Michel J, Pruliere Escabasse V,Béquignon E, et al. Guidelines of the French Society ofOtorhinolaryngology (SFORL). Second-line treatment ofepistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis.2017;134(3):191-193. doi:10.1016/j.anorl.2016.09.009

  7. Lin G, Bleier B. Surgical Management of Severe Epistaxis.Otolaryngol Clin North Am. 2016;49(3):627-37. doi:10.1016/j.otc.2016.01.003

  8. Monjas-Cánovas I, Hernández-García I, Mauri-Barberá J, Sanz-Romero B, Gras-Albert JR. Epidemiología de las epistaxisingresadas en un hospital de tercer nivel. Acta OtorrinolaringolEsp. 2010;61(1):41–7.

  9. Pallin DJ, Chng YM, McKay MP, Emond JA, Pelletier AJ,Camargo CA Jr. Epidemiology of epistaxis in US emergencydepartments, 1992 to 2001. Ann Emerg Med. 2005;46(1):77-81. doi:10.1016/j.annemergmed.2004.12.014

  10. Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosisand treatment. J Oral Maxillofac Surg. 2006;64(3):511-518.doi:10.1016/j.joms.2005.11.031

  11. Ando Y, Iimura J, Arai S, et al. Risk factors for recurrentepistaxis: importance of initial treatment. Auris Nasus Larynx.2014;41(1):41-45. doi:10.1016/j.anl.2013.05.004

  12. Corr MJ, Tikka T, Douglas CM, Marshall J. One-year all-causemortality for 338 patients admitted with epistaxis in a largetertiary ENT centre. J Laryngol Otol. 2019;133(6):487-493.doi:10.1017/S0022215119000860

  13. Newton E, Lasso A, Petrcich W, Kilty SJ. An outcomes analysisof anterior epistaxis management in the emergency department.J Otolaryngol Head Neck Surg. 2016;45:24. doi:10.1186/s40463-016-0138-2

  14. Kubba H, MacAndie C, Botma M, et al. A prospective, singleblind,randomized controlled trial of antiseptic cream forrecurrent epistaxis in childhood. Clin Otolaryngol Allied Sci.2001;26(6):465-468. doi:10.1046/j.1365-2273.2001.00502.x

  15. Abrich V, Brozek A, Boyle TR, Chyou PH, Yale SH. Riskfactors for recurrent spontaneous epistaxis. Mayo Clin Proc.2014;89(12):1636-1643. doi:10.1016/j.mayocp.2014.09.009

  16. Terakura M, Fujisaki R, Suda T, Sagawa T, Sakamoto T.Relationship between blood pressure and persistent epistaxisat the emergency department: a retrospective study. J Am SocHypertens. 2012;6(4):291-295. doi:10.1016/j.jash.2012.05.001

  17. Lubianca Neto JF, Fuchs FD, Facco SR, et al. Isepistaxis evidence of end-organ damage in patients withhypertension?. Laryngoscope. 1999;109(7 Pt 1):1111-15.doi:10.1097/00005537-199907000-00019

  18. Min HJ, Kang H, Choi GJ, Kim KS. Association betweenHypertension and Epistaxis: Systematic Review and Metaanalysis.Otolaryngol Head Neck Surg. 2017;157(6):921-927.doi:10.1177/0194599817721445




2020     |     www.medigraphic.com